A Trial of Panobinostat and Trastuzumab for Adult Female Patients With HER2 Positive Metastatic Breast Cancer (MBC) Whose Disease Has Progressed on or After Trastuzumab
Clinical trial NCT00567879 · TERMINATED
Trial details
- NCT number
- NCT00567879
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-04-01
- Primary completion
- 2011-05-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.